se of 64CuCl2 in urologic tumors

Completed

• Conditions: rologic tumors (kidney, prostate, bladder, penis); Cancer

• Registration Number: ISRCTN11735271
• Lead Sponsor: Ospedale Civile Spirito Santo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-21
• Last Update Posted: 18 December 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

1. Subject aged over 18 at diagnosis
2. Subject with renal or bladder or prostate or penile cancer waiting for surgical excision or imaging restaging due to progressive disease
3. Availability of already done cross-sectional imaging in the last month
4. Karnofsky index >80%
5. Absence of relevant comorbidities (see exclusion criteria)
6. Full mental ability to understand the value and the relevance of the protocol and the related procedures showed in the Informativa per il soggetto”
7. Full mental ability in order to give informed consent
8. Negative pregnancy test for women potentially at risk for pregnancies

Exclusion Criteria

1. Hb levels < 10 gr/dL
2. Presence of copper metabolism diseases (Menkes or Wilson diseases)
3. Previous participation in clinical trial involving ionizing radiation for diagnostic or therapeutic finality in the last year
4. Working exposition to ionizing radiation
5. Each condition that could alter and reduce the compliance of the subject to the participation to the study protocol
6. Mental inability to fully understand the Informativa per il soggetto”

Study & Design

• Study Type: Interventional
• Study Design: Not specified